SCHEMBL23558589

SCHEMBL23558589

O=C1CC(CO)(CO)Oc2ccc(-c3cc(-c4ccccc4CO)no3)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.33
▸ RAB9A P51151 5/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ NOTUM Q6P988 1/20 0.33
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ ABCB1 P08183 1/20 0.32
▸ ABCC1 P33527 1/20 0.32
▸ SCD5 Q86SK9 3/20 0.32
▸ HPGD P15428 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ MAPT P10636 4/20 0.32
▸ LMNA P02545 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23558481 0.89 RAB9A (0.42) NPC1RAB9ACYP1A2SMN1; SMN2CNR1
SCHEMBL25856949 0.85 CNR1 (0.41) NPC1RAB9ACYP1A2SMN1; SMN2CNR1
SCHEMBL23558330 0.83 RAB9A (0.40) NPC1RAB9ACYP1A2SMN1; SMN2CNR1
SCHEMBL23558568 0.83 HSD17B1 (0.46) NPC1RAB9ACYP1A2SMN1; SMN2ABCB1
SCHEMBL23558442 0.82 S1PR1 (0.42) NPC1RAB9ACYP1A2SMN1; SMN2ABCB1
SCHEMBL23558433 0.82 HSD17B1 (0.51) NPC1RAB9ASMN1; SMN2ABCB1ABCC1
SCHEMBL25856895 0.80 RAB9A (0.42) NPC1RAB9ACYP1A2SMN1; SMN2CNR1
SCHEMBL25856856 0.79 NPC1 (0.43) NPC1RAB9ACYP1A2SMN1; SMN2CNR1
SCHEMBL23558496 0.78 S1PR1 (0.35) NPC1RAB9ACYP1A2ABCB1ABCC1
SCHEMBL23558461 0.77 NPC1 (0.45) NPC1RAB9ACYP1A2SMN1; SMN2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 NPC1 301/4885RAB9A 3056/4885CYP1A2 4278/4885
US-20210188826-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 NPC1 301/4885RAB9A 3056/4885CYP1A2 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback